(Κύριος Ερευνητής: Αθανάσιος Αργύρης)
E1305 “A phase III randomized trial of Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer”, NCT00588770
https://clinicaltrials.gov/ct2/show/NCT00588770?term=E1305&rank=1
S1206 “A Dose Finding Study Followed by Phase II Randomized, Placebo-Controlled Study of Veliparib (ABT-888) Added to Chemoradiotherapy with Carboplatin, and Paclitaxel for Unresectable, Stage III Non-Small Cell Lung Cancer”, NCT01386385
https://clinicaltrials.gov/ct2/show/NCT01386385?term=S1206&rank=1
CheckMate 651. "An Open Label, Randomized, Two Arm Phase III Study of Nivolumab in Combination with Ipilimumab versus Extreme Study Regimen (cetuximab + cisplatin/carboplatin + fluorouracil) as First Line Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)"